3 Reasons EVH is Risky and 1 Stock to Buy Instead

Over the last six months, Evolent Health’s shares have sunk to $3.96, producing a disappointing 5.7% loss - a stark contrast to the S&P 500’s 9.1% gain. This might have investors contemplating their next move.